Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection
about
Methodological Issues in Cytokine Measurement in SchizophreniaPretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.Variables that affect assays for plasma cytokines and soluble activation markers.Need for an external proficiency testing program for cytokines, chemokines, and plasma markers of immune activationCytokine gene expression occurs more rapidly in stimulated peripheral blood mononuclear cells from human immunodeficiency virus-infected persons.Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures.Immunological effects of interleukin-2 therapy in human immunodeficiency virus-positive subjectsHIV and malnutrition: effects on immune system.Expanding role of circulating adhesion molecules in assessing prognosis and treatment response in human immunodeficiency virus infectionDifferent profile of cytokine synthesis according to the severity of acute pancreatitisDifferential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections.Stability of cytokines, chemokines and soluble activation markers in unprocessed blood stored under different conditionsUtility of Serum Neopterin and Serum IL-2 Receptor Levels to Predict Absolute CD4 T Lymphocyte Count in HIV Infected Cases.Measurement of Circulating Cytokines and Immune-Activation Markers by Multiplex Technology in the Clinical Setting: What Are We Really Measuring?Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy.The Initial Months of Antiretroviral Therapy and Its Influence on AGEs, HMGB1, and sRAGE Levels in Asymptomatic HIV-Infected Individuals.Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects.
P2860
Q26751839-3C276926-7645-4FD7-A48A-E9F8795E88DAQ33862741-5D7A33B5-D294-49DF-AEF9-6B7D3B324B19Q33997552-4EDFF14F-E3AD-4153-B6F7-D0A97A2B8E98Q33998456-55DC6570-0A41-4273-B5E3-A6E57683847CQ33998597-AEF4691A-E62D-4F8C-86F2-FD97D02A4B1DQ33999560-277D7B27-E71A-4F75-8F0B-87D9C93C1171Q34293966-8030D0D9-DAFC-4521-B8E1-63E50D1CEDB1Q35661554-1991794C-4C3F-4CAC-AD85-CC0BC8867DC5Q35946434-B93FE31B-5AB2-4776-A9AA-9FEAE4991FD6Q36213937-5B5547FF-08F7-4C06-A69B-78C584D355B7Q36915902-823BC42D-B901-4149-9552-E3DC13365622Q37012913-B969ABA0-F338-4DAA-8757-EF110BBA438DQ37408032-11B28FC0-8407-454A-9A50-DD3D0F302621Q37693694-51EF828A-243B-492B-BEB2-A769D20C4179Q38601647-F0C39042-69F0-4154-9907-11368DC3BED4Q39512269-3A86A805-51FE-452A-AFF4-2349099305E5Q43967318-2FDFC602-AE18-47BC-A762-69363CEE8E44
P2860
Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Cytokines, plasma immune activ ...... munodeficiency virus infection
@ast
Cytokines, plasma immune activ ...... munodeficiency virus infection
@en
type
label
Cytokines, plasma immune activ ...... munodeficiency virus infection
@ast
Cytokines, plasma immune activ ...... munodeficiency virus infection
@en
prefLabel
Cytokines, plasma immune activ ...... munodeficiency virus infection
@ast
Cytokines, plasma immune activ ...... munodeficiency virus infection
@en
P2860
P1476
Cytokines, plasma immune activ ...... munodeficiency virus infection
@en
P2093
P2860
P304
P577
1998-09-01T00:00:00Z